Nguyen AnhCo's Form 4 filing
Atara Biotherapeutics, Inc. (ATRA) · filed Aug 26, 2026
- Accession no.
- 0000905148-26-003960
- Filed
- Aug 26, 2026, 7:45 PM ET
- Trade date
- Aug 17, 2026
- Filing delay
- 9 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $40.9K. It was filed 9 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nguyen AnhCoCIK 0001977970 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Common Stock | SSaleDisposed | −5,062 | $8.08 | −$40,882.74 | 132,775 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.